
Investing in innovative medicines and vaccines doesn’t just save lives - it transforms our future. It strengthens health, drives economic growth, and improves health security. #AlwaysInnovating

We represent the innovative pharmaceutical industry globally, with a focus on three priorities: innovation, equitable access, and ethics. #AlwaysInnovating

Investing in innovative medicines and vaccines doesn’t just save lives - it transforms our future. It strengthens health, drives economic growth, and improves health security. #AlwaysInnovating

#CVRM conditions, including diabetes, make up almost 50% of all NCD deaths. This #WorldDiabetesDay, discover how innovation is transforming how we detect and treat them 👇 ifpma.org/areas-of-work/adva…

People with cardiovascular disease are nearly 4x more likely to develop pneumococcal disease, which can lead to pneumonia. Pneumococcal vaccination can lower the risk of any cardiovascular event by 14% 👇 ifpma.org/insights/longer-he… #WorldPneumoniaDay

Global average life expectancy rose from around 51 years in 1960 to 72 years in 2023. Sustained investment in innovation and prevention can help people live not only longer but healthier lives 👇 ifpma.org/initiatives/always… @beautiful__news

From patient experiences to foundational scientific data, pharma R&D draws on many types of data. Used responsibly, data can accelerate new medicines and vaccines, and a data ecosystem that supports innovation helps patients benefit sooner. ifpma.org/areas-of-work/fost…

With 4,700+ potential cancer medicines in development, partnerships in LMICs are key to making sure these innovations reach the people who need them. @DavidReddyIFPMA makes the case for investing in innovation in Cancer Control 2026 👇 cancercontrol.info/cc26-cont…

Influenza vaccination can generate up to USD 22 in societal benefits for every USD 1 invested. This #WorldFluDay, discover the value of every 1% increase in coverage 👇 ifpma.org/resources/the-valu…

Longer lives bring both opportunities and challenges. In @japantimes, @DavidReddyIFPMA and @JPMA’s @Go Takahashi explain how prevention can help older adults stay healthy and independent for longer 👇 japantimes.co.jp/commentary/…

A strong IP system helps turn scientific ideas into health breakthroughs. @DavidReddyIFPMA on what @WIPO’s #GlobalInnovationIndex highlights about innovation ecosystems 👇 ifpma.org/insights/from-pilo…

Vulnerability does not begin at 65. Discover how treating preventive care as an investment can help Europe turn longer lives into stronger economies and set a global example 👇 ifpma.org/insights/longer-he…

#NCDs are both a health and an economic challenge. IFPMA Executive Director, Global Health, Access, and Financing, Derrick Sim, makes the case for treating NCDs as an investment in healthier lives, stronger labor markets, and more resilient economies 👇 linkedin.com/pulse/case-trea…

Pharmaceutical innovation is not only an investment in health, but also in economic growth and resilience. @IFPMA Director General Dr. David Reddy examines why sustained investment in research and innovation is critical to healthier populations and stronger economies. #HealthAPoliticalChoice #WHS2026 #HealthInnovation #GlobalHealth @WorldHealthSmt @IFPMA globalgovernancemedia.org/ph…

On #WorldHeartDay, we’re reminded how prevention and innovation help people live healthier lives. CVRM conditions drive nearly half of NCD deaths, yet new diagnostics and treatments are transforming how we manage their interconnected progression. 🔗 ifpma.org/areas-of-work/adva…


Fostering innovation, strengthening health systems, and effective partnerships must be global priorities for today's global health architecture reform. Read the op-ed by @DavidReddyIFPMA on @HealthPolicyWatch 👇 healthpolicy-watch.news/the-…

Adult #immunization is vital for healthy aging. By 2060, adults 55–64 will be 30% of the workforce. Each $1 invested returns up to 19×, while preventable diseases cost G20 economies $1T yearly. 🔗 Learn more: ifpma.org/publications/adult…